Company / EPS (Basic)
GYRE THERAPEUTICS, INC. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.14
FY2025
5-year range
-$1.41 / $0.14
FY2022-FY2025
Trend
+109.9%
vs FY2024
Sector context
#43 of 208
Health Care
What the data says
GYRE THERAPEUTICS, INC.'s eps (basic) of $0.14 is higher than 79% of companies in the Health Care sector (FY2025). Improved from $0.04 to $0.14 over the past 2 years.
Based on SEC 10-K filings.
0.14 in FY2025 with a 3-year CAGR of +51.8%. Top quartile in the Health Care sector.
Improved from $0.04 to $0.14 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +51.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 208This company $0.14 Sector average -$0.96
▼
+114.5% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 109.9% year-over-year.
- Ranks #43 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | +109.9% |
| FY2024 | -$1.41 | -3625.0% |
| FY2023 | $0.04 | +0.0% |
| FY2022 | $0.04 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026